Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $262,374 - $322,888
-1,184 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $213,771 - $276,511
1,184 New
1,184 $272,000
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $455,988 - $590,298
-2,775 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $69,847 - $84,060
-512 Reduced 15.58%
2,775 $455,000
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $15,952 - $19,744
134 Added 4.25%
3,287 $466,000
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $49,076 - $60,785
-459 Reduced 12.71%
3,153 $415,000
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $250,956 - $272,976
-2,350 Reduced 39.42%
3,612 $405,000
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $309,214 - $360,932
-2,791 Reduced 31.89%
5,962 $659,000
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $102,739 - $120,931
-923 Reduced 9.54%
8,753 $1.13 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $74,553 - $83,522
-704 Reduced 6.78%
9,676 $1.11 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $28,333 - $35,412
-330 Reduced 3.08%
10,380 $1.12 Million
Q2 2018

Aug 03, 2018

BUY
$75.7 - $86.88 $15,897 - $18,244
210 Added 2.0%
10,710 $915,000
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $4,823 - $5,694
65 Added 0.62%
10,500 $811,000
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $60,307 - $64,687
736 Added 7.59%
10,435 $881,000
Q3 2017

Nov 03, 2017

BUY
$77.07 - $85.54 $24,970 - $27,714
324 Added 3.46%
9,699 $828,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,375
9,375 $769,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Brown Advisory Securities, LLC Portfolio

Follow Brown Advisory Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Securities, LLC with notifications on news.